Literature DB >> 597618

[Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)].

R Zimmermann, W Ehlers, F Manz, W Meinrenken, R Egbring, H Gemmeke.   

Abstract

An infant with congenital homozygous factor XIII deficiency demonstrated a severe retroperitoneal and intracerebral bleeding with development of a posthemorrhagic hydrocephalus in the first months of life. Factor XIII activity was not measurable by means of enzymatic method and the antiserum inhibition test. Quantitative immunoelectrophoresis according to Laurell presented absence of the subunit A, whereas the concentration of subunit S was reduced to 47% the normal value. After replacement therapy factor XIII activity was estimated at 23% and corresponded to the concentration of the subunit A, concentration of subunit S increased by 20%. The turnover rate of fibrin stabilizing factor could be observed over a period of 39 days. The half life was estimated at 4,7 days. The child developed normally after continous substitution with 250 units of factor XIII concentrate every 6 weeks.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 597618     DOI: 10.1007/bf00996692

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  22 in total

1.  On the Solubility of Fibrin Clots.

Authors:  K Laki; L Lóránd
Journal:  Science       Date:  1948-09-10       Impact factor: 47.728

2.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.

Authors:  M L Schwartz; S V Pizzo; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

3.  [Isolation and characterization of a fibrin-stabilizing factor from human placenta].

Authors:  H Bohn; H G Schwick
Journal:  Arzneimittelforschung       Date:  1971-10

4.  Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiency.

Authors:  T Barbui; G Cartei; T Chisesi; E Dini
Journal:  Thromb Diath Haemorrh       Date:  1974-09-30

5.  Documentation of the plasma factor XIII deficiency in man.

Authors:  F Duckert
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

6.  [Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)].

Authors:  R Egbring; W Schmidt; K Havemann
Journal:  Blut       Date:  1973-07

7.  [Immunological studies on factor XIII and FSF-binding globulin].

Authors:  H Bohn
Journal:  Blut       Date:  1974-02

8.  [Substitution treatment of factor XIII deficiency with a new factor XIII concentrate].

Authors:  H Trobisch; R Egbring
Journal:  Dtsch Med Wochenschr       Date:  1972-03-31       Impact factor: 0.628

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature.

Authors:  A F Britten
Journal:  Am J Med       Date:  1967-11       Impact factor: 4.965

View more
  1 in total

Review 1.  Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?

Authors:  Wolfgang Korte
Journal:  J Blood Med       Date:  2014-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.